These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 17342060)
21. Molecular characterization of the HIV type 1 subtype C accessory genes vif, vpr, and vpu. Bell CM; Connell BJ; Capovilla A; Venter WD; Stevens WS; Papathanasopoulos MA AIDS Res Hum Retroviruses; 2007 Feb; 23(2):322-30. PubMed ID: 17331040 [TBL] [Abstract][Full Text] [Related]
22. Codon pairs of the HIV-1 vif gene correlate with CD4+ T cell count. Bizinoto MC; Yabe S; Leal É; Kishino H; Martins Lde O; de Lima ML; Morais ER; Diaz RS; Janini LM BMC Infect Dis; 2013 Apr; 13():173. PubMed ID: 23578255 [TBL] [Abstract][Full Text] [Related]
23. Unimpaired function of a naturally occurring C terminally truncated vif gene product of human immunodeficiency virus type 1. Ochsenbauer C; Bosch V; Oelze I; Wieland U J Gen Virol; 1996 Jul; 77 ( Pt 7)():1389-95. PubMed ID: 8757978 [TBL] [Abstract][Full Text] [Related]
24. Amino acid residues 88 and 89 in the central hydrophilic region of human immunodeficiency virus type 1 Vif are critical for viral infectivity by enhancing the steady-state expression of Vif. Fujita M; Sakurai A; Yoshida A; Miyaura M; Koyama AH; Sakai K; Adachi A J Virol; 2003 Jan; 77(2):1626-32. PubMed ID: 12502880 [TBL] [Abstract][Full Text] [Related]
25. Analysis of the N-terminal positively charged residues of the simian immunodeficiency virus Vif reveals a critical amino acid required for the antagonism of rhesus APOBEC3D, G, and H. Schmitt K; Katuwal M; Wang Y; Li C; Stephens EB Virology; 2014 Jan; 449():140-9. PubMed ID: 24418547 [TBL] [Abstract][Full Text] [Related]
26. Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly. Stanley BJ; Ehrlich ES; Short L; Yu Y; Xiao Z; Yu XF; Xiong Y J Virol; 2008 Sep; 82(17):8656-63. PubMed ID: 18562529 [TBL] [Abstract][Full Text] [Related]
27. Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity. Ma XY; Sova P; Chao W; Volsky DJ J Virol; 1994 Mar; 68(3):1714-20. PubMed ID: 8107232 [TBL] [Abstract][Full Text] [Related]
28. A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein. Guy B; Geist M; Dott K; Spehner D; Kieny MP; Lecocq JP J Virol; 1991 Mar; 65(3):1325-31. PubMed ID: 1995946 [TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of HIV type 1 vif sequences from Cape Town, South Africa. Jacobs GB; Nistal M; Laten A; van Rensburg EJ; Rethwilm A; Preiser W; Bodem J; Engelbrecht S AIDS Res Hum Retroviruses; 2008 Jul; 24(7):991-4. PubMed ID: 18593349 [TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of two Schistosoma mansoni proteins sharing common motifs with the vif protein of HIV-1. Khalife J; Pierce RJ; Godin C; Capron A Parasitology; 1994 Jun; 108 ( Pt 5)():533-42. PubMed ID: 8052509 [TBL] [Abstract][Full Text] [Related]
32. Sequence analysis of HIV-1 vif gene in Spanish isolates. Olivares I; Menéndez-Arias L; Rodríguez-Bernabé A; Martin MJ; Dopazo J; López-Galíndez C Virus Genes; 1995 Feb; 9(3):283-8. PubMed ID: 7597807 [TBL] [Abstract][Full Text] [Related]
33. Mutational analysis of the human immunodeficiency virus type 1 Vif protein. Simon JH; Sheehy AM; Carpenter EA; Fouchier RA; Malim MH J Virol; 1999 Apr; 73(4):2675-81. PubMed ID: 10074113 [TBL] [Abstract][Full Text] [Related]
34. The human immunodeficiency virus type 1 vif gene: the road from an accessory to an essential role in human immunodeficiency virus type 1 replication. Volsky DJ; Potash MJ; Simm M; Sova P; Ma XY; Chao W; Shahabuddin M Curr Top Microbiol Immunol; 1995; 193():157-68. PubMed ID: 7648874 [No Abstract] [Full Text] [Related]
35. Cell-free transmission of Vif mutants of HIV-1. Fan L; Peden K Virology; 1992 Sep; 190(1):19-29. PubMed ID: 1529528 [TBL] [Abstract][Full Text] [Related]
36. APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus-1 infection. Gourraud PA; Karaouni A; Woo JM; Schmidt T; Oksenberg JR; Hecht FM; Liegler TJ; Barbour JD Hum Immunol; 2011 Mar; 72(3):207-12. PubMed ID: 21167246 [TBL] [Abstract][Full Text] [Related]
37. Effects of lysine to arginine mutations in HIV-1 Vif on its expression and viral infectivity. Khamsri B; Fujita M; Kamada K; Piroozmand A; Yamashita T; Uchiyama T; Adachi A Int J Mol Med; 2006 Oct; 18(4):679-83. PubMed ID: 16964423 [TBL] [Abstract][Full Text] [Related]
38. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. Gabuzda DH; Lawrence K; Langhoff E; Terwilliger E; Dorfman T; Haseltine WA; Sodroski J J Virol; 1992 Nov; 66(11):6489-95. PubMed ID: 1357189 [TBL] [Abstract][Full Text] [Related]
39. Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation. Pace C; Keller J; Nolan D; James I; Gaudieri S; Moore C; Mallal S J Virol; 2006 Sep; 80(18):9259-69. PubMed ID: 16940537 [TBL] [Abstract][Full Text] [Related]
40. Analysis of the cell-dependent replication potentials of human immunodeficiency virus type 1 vif mutants. Fujita M; Sakurai A; Doi N; Miyaura M; Yoshida A; Sakai K; Adachi A Microbes Infect; 2001 Nov; 3(13):1093-9. PubMed ID: 11709289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]